in 14 pts. Importantly, there was significant difference in MS clinical severity of group A versus group B (EDSS 1.8Ϯ1.3 vs 3.0Ϯ2.2, pϽ0.05), as well as compare to group C (EDSS group B vs group C 3.0Ϯ2.2 vs 5.0Ϯ2.2, pϽ0.005). Similarly, there was significant difference in MS duration in group A versus group C (4Ϯ3 years versus 9Ϯ5 years, pϽ0.005).
Background:
To study early and 1-year outcomes of carotid artery stenting (CAS) and carotid endaterectomy (CEA) in patient with medical comorbidities according to Euroscore risk evaluation model. Methods: We retrospectively reviewed 312 patients who were treated for symptomatic carotid stenosis between 2002 and 2012 (142 CASs and 170 carotid endarterectomies CEAs) Results: Patients undergoing CEA were older than CAS (78 years vs. 70 years, P ϭ 0.001). Embolic protection devices were used in 98.6% of cases. Depending on comorbidities all patient were divided in two groups: EuroSCORE Յ 20 (n -181) and . In EuroSCORE Յ 20 group CAS was performed in 75 patients, CEA -in 106 patients. The 30-days stroke rate did not differ between subgroups (2.7% in CAS vs. 1.9% CEA, p Ͼ 0.05). The 1-year freedom from stroke were 93.4% in CAS subgroup and 94.3% in CEA subgroup (p Ͼ 0.05). There was no difference in the all-cause death rate (stroke-related, coronary, other) at 1-year follow-up (2.7% in CAS subgroup vs 4.9%, p Ͼ 0.05). In EuroSCORE Ͼ 20 group CAS was performed in 73 patients, CEA -in 58 patients. There was no difference in the incidence of 30-days stroke (2.8% in CAS vs. 1.7% CEA, p Ͼ 0.05). The 1-year freedom from stroke were 93.2% in CAS subgroup and 94.9% in CEA subgroup (p Ͼ 0.05). The all-cause death rate among CAS patients was lower (1.4%) compared to CEA patients (12%, p ϭ 0.044). Univariate analysis in patients undergoing CAS showed that and age Ͼ 70 years was related with postprocedural neurological complications (p ϭ 0.046). However, age was not independent risk factors on multivariate analysis Conclusions: In the low-risk patients (EuroSCORE Յ 20) the rates of peri-procedural, long-term neurological complications and all-cause death rate did not differ between CAS and CEA subgroups. In high-risk patients (EuroSCORE Ͼ 20) there was no significant difference in the incidence of peri-procedural and long-term neurological complications between subgroups, but patients after CEA are at higher risk for any-cause related death.
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The Transradial Approach is Safe and Effective for Carotid Artery Stenting
Sasko Kedev 1 , Slobodan Antov 1 , Danica Petkoska 1 , Tift Mann 2 1 University Clinic of Cardiology, Skopje, Macedonia, The Former Yugoslav Republic of, 2 N/A, Raleigh, North Carolina Background: Carotid artery stenting (CAS) is viable alternative to carotid endarterectomy (CEA). Femoral access for CAS may be problematic due to peripheral vascular disease, anatomical variations of the aortic arch, and access site complications. The primary endpoint of this study was to evaluate the right transradial approach (TRA) for CAS. Methods: A retrospective analysis of all 420 pts that underwent TRA CAS at two centers was performed. Demographics, the technique used to deploy the sheath in the common carotid, procedural details, results, and complications were evaluated. Results: CAS was attempted from TRA in 420 pts (mean age 69, 72% male). Comorbidities increasing the risk of CEA were present in 334(79%) and 213(51%) were symptomatic. CAS was successful in 395/420 (94%) pts; 239/254 (94%) right CA, 15/17 (88%) bovine left CA, 181/199 (91%) left CA. The specific technique varied with the anatomy. The initial diagnostic catheter for RCA was Simmons 1 (25%) or Simmons 2 (more acute angle) (52%); for bovine left CA an Amplatz R2 (36%) or Simmons (more vertical takeoff) (29%); and for non-bovine left CA a wire-braided Simmons 2 (77%). The diagnostic catheter was then exchanged for a 5F (26%) or 6F (69%) sheath or 7F guide (5%) over an .035Љ standard (4%) or Amplatz superstiff guidewire (73%), or Glidewire (23%). In more recent cases, a one-step method advancing a TAD II guidewire directly into the external for shuttle sheath exchange was utilized (6%). Seven different carotid artery stents (50% Xact) and 7 different distal embolic protection devices were used. Adverse events included 2 major strokes (0.48%) one of whom died, 4 minor strokes (0.96%), and no myocardial infarction at 30 days. No bleeding complications occurred although 23 (6%) of patients had asymptomatic post-procedure radial occlusion. Inadequate catheter support at the origin of the CCA was the technical cause of failure in the unsuccessful cases that were completed from femoral access as part of the same procedure.
Conclusions:
The transradial approach is save, consistent and efficient technique for CAS in the presence of factors that increase the risk or difficulty of femoral access. Background: Cerebral ischemia secondary to severe stenosis of the major arch vessels is a well known phenomenon in Takayasu arteritis. Significant obstruction of one or more arteries supplying the brain can lead to ischemic CVA, syncope, transient ischemic attack, or visual impairment. In the past 5 years we had 18 patients with Takayasu arteritis with such symptoms in whom 22 lesions were subjected to angioplasty with stenting. Methods: During the period April, 2007 to march, 2012, total 24 patients that were diagnosed to have Takayasu arteritis showed symptoms of cerebral ischemia. Of them 18 patients (22 lesions in supraaortic arteries-carotid, vertebral or brachiocephalic) with age ranging from 24 yr to 48 yr (mean age 27.6 Ϯ 1.15 years) underwent angioplasty with stenting to one or more lesions. The procedural details and acute and follow-up data of these 18 cases was analysed in this study. Results: Angioplasty was attempted on 22 lesions (carotid-10, vertebral-6, and brachiocephalic-6). The procedure was successfully completed in 20 out of 22 lesions. Bare-metal stents were deployed in all 20 cases (rapid exchange system-12 and over-the-wire system-8; balloon-expandable-8 and self-expandable-12).The wire could not cross 2 lesions with total occlusion of brachiocephalic arteries. Two had suboptimal result with Ͼ 20% residual stenosis. One case of carotid angioplasty had TIA and another had seizures after 3 hours of the procedure. In one case there was femoral pseudoaneurysm which could be managed conservatively. On follow-up there was marked symptomatic relief in 17 of the 18 cases (94.4%). Only 12 cases came for follow-up angiograms at a mean period of 7.45 Ϯ 1.25 months and 3 (25%) had restenosis. Conclusions: Angioplasty and stenting of the significant lesions in supra-aortic vessels in symptomatic patients with Takayasu arteritis showed acceptable acute success. The symptomatic relief was well maintained most of the patients at follow-up. 
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